Madrigal Pharmaceuticals Inc <MDGL.O>: BofA Global Research cuts price objective to $543 from $553
MDGL•Related News
E& Completes Sale Of 12.5% Stake In Careem Technologies To Uber
UBER•
Cboe Global Markets Q2 Adjusted EPS USD 3.56 Vs. IBES Estimate USD 3.48
CBOE•
Nextpower Inc <NXT.O>: Truist Securities raises target price to $145 from $140
NXT•
Kazakhstan's Tengizchevroil resumes exports from Georgia's Batumi amid CPC stoppage, two sources say
CVX•
Ballard Q2 FY26 net loss narrows 16% to $20.3 million; revenue rises 15% to $20.6 million
BLDP•